Product Name:Triphenylmethyl chloride

IUPAC Name:

CAS:76-83-5
Molecular Formula:C19H15Cl
Purity:95%+
Catalog Number:CM000181
Molecular Weight:278.78

Packing Unit Available Stock Price($) Quantity
CM000181-500g 1-2 Weeks Ǖȁ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:76-83-5
Molecular Formula:C19H15Cl
Melting Point:-
Smiles Code:ClC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
Density:
Catalog Number:CM000181
Molecular Weight:278.78
Boiling Point:
MDL No:MFCD00000813
Storage:

Column Infos

Zegocractin
CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.